These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 16323147)

  • 61. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 62. [Measles: notes on epidemiology and prevention, including the military community].
    Zardi O
    Riv Med Aeronaut Spaz; 1979; 42(1-2):124-60. PubMed ID: 400041
    [No Abstract]   [Full Text] [Related]  

  • 63. The sero-epidemiology of measles in children from Eastern Turkey.
    Altinkaynak S; Ertekin V; Güraksin A; Kiliç A; Yiğit N
    West Indian Med J; 2005 Sep; 54(4):236-7. PubMed ID: 16312189
    [No Abstract]   [Full Text] [Related]  

  • 64. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
    Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
    East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease.
    Jallow S; Cutland CL; Masbou AK; Adrian P; Madhi SA
    J Clin Virol; 2017 Sep; 94():50-56. PubMed ID: 28759772
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Waning immunity and subclinical measles infections in England.
    Glass K; Grenfell BT
    Vaccine; 2004 Sep; 22(29-30):4110-6. PubMed ID: 15364464
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dynamics of measles immunity from birth and following vaccination.
    Wang W; O'Driscoll M; Wang Q; Zhao S; Salje H; Yu H
    Nat Microbiol; 2024 Jul; 9(7):1676-1685. PubMed ID: 38740931
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Humoral immunity indices of measles in reinoculated schoolchildren].
    Miroshnikova NK; Smorodinova IP; Smorodintsev AA; Petrova VN
    Tr Inst Im Pastera; 1983; 61():145-51. PubMed ID: 6235627
    [No Abstract]   [Full Text] [Related]  

  • 69. Optimum age of measles immunization--maternal and transplacentally transmitted measles antibodies in infancy.
    Mohan M; Mehta PK; Sehgal S; Prabhakar AK; Bhargava SK
    Indian Pediatr; 1981 Sep; 18(9):631-5. PubMed ID: 7319611
    [No Abstract]   [Full Text] [Related]  

  • 70. Laboratory investigations are indispensable to monitor the progress of measles elimination--results of the German Measles Sentinel 1999-2003.
    Tischer A; Santibanez S; Siedler A; Heider A; Hengel H
    J Clin Virol; 2004 Nov; 31(3):165-78. PubMed ID: 15465408
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sero-epidemiological survey of measles in Alwar, Rajasthan.
    Sharma RS; Ray K; Grover SS; Behl JP
    J Commun Dis; 1986 Mar; 18(1):6-8. PubMed ID: 3745866
    [No Abstract]   [Full Text] [Related]  

  • 72. [History of purification, attenuation and testing a measles vaccine made from the strain "Leningrad-16" (L-16)].
    Smorodintsev AA; Taros LIu
    Tr Inst Im Pastera; 1992; 67():86-95. PubMed ID: 8539772
    [No Abstract]   [Full Text] [Related]  

  • 73. [Revaccination of children inoculated against measles].
    Bolotovskiĭ VM; Titova NS; Bakhur EA; Tamm OM; Miartin IaK
    Pediatriia; 1981 Dec; (12):46-8. PubMed ID: 7335425
    [No Abstract]   [Full Text] [Related]  

  • 74. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns.
    Leuridan E; Van Damme P
    Vaccine; 2007 Aug; 25(34):6296-304. PubMed ID: 17629601
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modifications of IFN-alpha, TNF-alpha and IFN-gamma serum levels in children vaccinated against measles.
    Liguori G; Tolone C; D'Avanzo M; Corbisiero G; Di Benedetto R; Del Prete U
    Ann Ig; 1998; 10(5-6):303-6. PubMed ID: 10052194
    [No Abstract]   [Full Text] [Related]  

  • 77. [Measles: immunity and vaccination status in Greater Frankfurt on the Main].
    Friedrichs I; Doerr HW; Allwinn R
    Dtsch Med Wochenschr; 2012 Jan; 137(4):121-5. PubMed ID: 22259164
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The strength of postvaccinal measles immunity in schoolchildren].
    Smorodinova IP; Miroshnikova NK; Sobolevskaia AA
    Tr Inst Im Pastera; 1985; 62():46-50. PubMed ID: 2954275
    [No Abstract]   [Full Text] [Related]  

  • 79. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 80. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
    Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
    Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.